vs

Side-by-side financial comparison of Eastman Chemical Company (EMN) and Ingersoll Rand (IR). Click either name above to swap in a different company.

Ingersoll Rand is the larger business by last-quarter revenue ($2.1B vs $2.0B, roughly 1.1× Eastman Chemical Company). Ingersoll Rand runs the higher net margin — 12.7% vs 5.3%, a 7.4% gap on every dollar of revenue. On growth, Ingersoll Rand posted the faster year-over-year revenue change (10.1% vs -13.8%). Over the past eight quarters, Ingersoll Rand's revenue compounded faster (11.9% CAGR vs -8.6%).

Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.

Ingersoll Rand Inc. is an American multinational company that provides flow creation and industrial products. The company was formed in February 2020 through the spinoff of the industrial segment of Ingersoll-Rand plc and its merger with Gardner Denver. Its products are sold under more than 40 brands across all major global markets.

EMN vs IR — Head-to-Head

Bigger by revenue
IR
IR
1.1× larger
IR
$2.1B
$2.0B
EMN
Growing faster (revenue YoY)
IR
IR
+24.0% gap
IR
10.1%
-13.8%
EMN
Higher net margin
IR
IR
7.4% more per $
IR
12.7%
5.3%
EMN
Faster 2-yr revenue CAGR
IR
IR
Annualised
IR
11.9%
-8.6%
EMN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EMN
EMN
IR
IR
Revenue
$2.0B
$2.1B
Net Profit
$105.0M
$266.1M
Gross Margin
17.1%
42.6%
Operating Margin
18.7%
Net Margin
5.3%
12.7%
Revenue YoY
-13.8%
10.1%
Net Profit YoY
-42.3%
15.8%
EPS (diluted)
$0.93
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMN
EMN
IR
IR
Q1 26
$2.0B
Q4 25
$2.0B
$2.1B
Q3 25
$2.2B
$2.0B
Q2 25
$2.3B
$1.9B
Q1 25
$2.3B
$1.7B
Q4 24
$2.2B
$1.9B
Q3 24
$2.5B
$1.9B
Q2 24
$2.4B
$1.8B
Net Profit
EMN
EMN
IR
IR
Q1 26
$105.0M
Q4 25
$105.0M
$266.1M
Q3 25
$47.0M
$244.1M
Q2 25
$140.0M
$-115.3M
Q1 25
$182.0M
$186.5M
Q4 24
$330.0M
$229.8M
Q3 24
$180.0M
$221.6M
Q2 24
$230.0M
$185.0M
Gross Margin
EMN
EMN
IR
IR
Q1 26
17.1%
Q4 25
17.1%
42.6%
Q3 25
19.7%
43.7%
Q2 25
22.1%
43.7%
Q1 25
24.8%
44.6%
Q4 24
24.7%
42.9%
Q3 24
24.6%
43.8%
Q2 24
25.3%
43.9%
Operating Margin
EMN
EMN
IR
IR
Q1 26
Q4 25
0.6%
18.7%
Q3 25
6.1%
19.2%
Q2 25
7.4%
4.0%
Q1 25
11.0%
17.6%
Q4 24
13.2%
20.0%
Q3 24
11.4%
19.1%
Q2 24
12.1%
15.1%
Net Margin
EMN
EMN
IR
IR
Q1 26
5.3%
Q4 25
5.3%
12.7%
Q3 25
2.1%
12.5%
Q2 25
6.1%
-6.1%
Q1 25
7.9%
10.9%
Q4 24
14.7%
12.1%
Q3 24
7.3%
11.9%
Q2 24
9.7%
10.2%
EPS (diluted)
EMN
EMN
IR
IR
Q1 26
$0.93
Q4 25
$0.93
$0.67
Q3 25
$0.40
$0.61
Q2 25
$1.20
$-0.29
Q1 25
$1.57
$0.46
Q4 24
$2.81
$0.57
Q3 24
$1.53
$0.54
Q2 24
$1.94
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMN
EMN
IR
IR
Cash + ST InvestmentsLiquidity on hand
$566.0M
$1.2B
Total DebtLower is stronger
$4.8B
Stockholders' EquityBook value
$6.0B
$10.1B
Total Assets
$14.9B
$18.3B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMN
EMN
IR
IR
Q1 26
$566.0M
Q4 25
$566.0M
$1.2B
Q3 25
$1.2B
Q2 25
$1.3B
Q1 25
$1.6B
Q4 24
$837.0M
$1.5B
Q3 24
$1.4B
Q2 24
$1.1B
Total Debt
EMN
EMN
IR
IR
Q1 26
Q4 25
$4.8B
Q3 25
$4.8B
Q2 25
$4.8B
Q1 25
$4.8B
Q4 24
$4.8B
Q3 24
$4.8B
Q2 24
$4.8B
Stockholders' Equity
EMN
EMN
IR
IR
Q1 26
$6.0B
Q4 25
$6.0B
$10.1B
Q3 25
$5.8B
$10.1B
Q2 25
$5.8B
$10.1B
Q1 25
$5.9B
$10.5B
Q4 24
$5.8B
$10.2B
Q3 24
$5.7B
$10.3B
Q2 24
$5.6B
$10.0B
Total Assets
EMN
EMN
IR
IR
Q1 26
$14.9B
Q4 25
$14.9B
$18.3B
Q3 25
$15.0B
$18.2B
Q2 25
$15.2B
$18.1B
Q1 25
$15.0B
$18.4B
Q4 24
$15.2B
$18.0B
Q3 24
$15.1B
$18.2B
Q2 24
$14.9B
$17.8B
Debt / Equity
EMN
EMN
IR
IR
Q1 26
Q4 25
0.47×
Q3 25
0.47×
Q2 25
0.47×
Q1 25
0.45×
Q4 24
0.47×
Q3 24
0.47×
Q2 24
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMN
EMN
IR
IR
Operating Cash FlowLast quarter
$499.0M
Free Cash FlowOCF − Capex
$461.5M
FCF MarginFCF / Revenue
22.1%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
1.88×
TTM Free Cash FlowTrailing 4 quarters
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMN
EMN
IR
IR
Q1 26
Q4 25
$502.0M
$499.0M
Q3 25
$402.0M
$354.6M
Q2 25
$233.0M
$245.7M
Q1 25
$-167.0M
$256.4M
Q4 24
$540.0M
$526.2M
Q3 24
$396.0M
$404.0M
Q2 24
$367.0M
$304.9M
Free Cash Flow
EMN
EMN
IR
IR
Q1 26
Q4 25
$390.0M
$461.5M
Q3 25
$265.0M
$325.5M
Q2 25
$83.0M
$210.4M
Q1 25
$-314.0M
$222.7M
Q4 24
$361.0M
$490.9M
Q3 24
$276.0M
$374.3M
Q2 24
$252.0M
$283.1M
FCF Margin
EMN
EMN
IR
IR
Q1 26
Q4 25
19.8%
22.1%
Q3 25
12.0%
16.6%
Q2 25
3.6%
11.1%
Q1 25
-13.7%
13.0%
Q4 24
16.1%
25.9%
Q3 24
11.2%
20.1%
Q2 24
10.7%
15.7%
Capex Intensity
EMN
EMN
IR
IR
Q1 26
Q4 25
5.7%
1.8%
Q3 25
6.2%
1.5%
Q2 25
6.6%
1.9%
Q1 25
6.4%
2.0%
Q4 24
8.0%
1.9%
Q3 24
4.9%
1.6%
Q2 24
4.9%
1.2%
Cash Conversion
EMN
EMN
IR
IR
Q1 26
Q4 25
4.78×
1.88×
Q3 25
8.55×
1.45×
Q2 25
1.66×
Q1 25
-0.92×
1.37×
Q4 24
1.64×
2.29×
Q3 24
2.20×
1.82×
Q2 24
1.60×
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMN
EMN

Segment breakdown not available.

IR
IR

Transferred At Point In Time$1.5B71%
Transferred Over Time$193.0M9%
Precision And Science Technologies Segment$183.1M9%
Acquisitions In2024$175.6M8%
Acquisitions In2025$70.8M3%

Related Comparisons